Mustafa Arslan | Nanomedicine | Best Researcher Award

Prof. Dr. Mustafa Arslan | Nanomedicine | Best Researcher Award

Prof. Dr. at Gazi University, Medical Faculty, Turkey.

Prof. Mustafa Arslan is a distinguished medical researcher and professor at Gazi University, specializing in surgery and fundamental medical sciences. With a career spanning over two decades, he has made significant contributions to medical research, particularly in experimental and clinical studies. As the Director of the Experimental and Clinical Research Center at Gazi University, he has played a crucial role in advancing surgical and anesthesia-related research. His extensive academic involvement includes serving on multiple ethics committees, supervising research projects, and mentoring doctoral students. Prof. Arslan has published widely in high-impact medical journals and is recognized for his expertise in ischemia-reperfusion injury models. His active participation in academic and administrative roles highlights his leadership in medical sciences. With a strong presence in international research databases such as Scopus, Web of Science, and Google Scholar, he has established himself as a key figure in medical research. His dedication to medical education, research ethics, and innovative surgical techniques positions him as a leading expert in his field. Prof. Arslan continues to contribute significantly to medical advancements through his research, teaching, and leadership, making him a highly respected figure in the global medical community.

Professional Profile:

Education

Prof. Mustafa Arslan has an extensive educational background in medicine, reflecting his commitment to academic excellence and medical research. He earned his undergraduate degree from Ege University, Faculty of Medicine, in 1994, laying a strong foundation for his future career in surgery and medical sciences. He then pursued an advanced specialization in medicine at Erciyes University, where he focused on fundamental medical sciences from 1999 to 2001. Continuing his academic journey, he obtained further expertise in surgery from Gazi University’s Faculty of Medicine between 2001 and 2006. His dissertation research at Gazi University focused on the comparative effects of desflurane and sevoflurane on rat liver, emphasizing gender and age-related differences. Additionally, his earlier research at Erciyes University explored electrophysiological and electrodermal activity changes in Behçet’s disease, demonstrating his interdisciplinary approach to medicine. Prof. Arslan has also undertaken specialized training in experimental animal research, completing certification in laboratory animal studies at Erciyes University in 2003. His continuous pursuit of knowledge and specialization in surgical and experimental medicine has shaped his career as a researcher and educator, enabling him to contribute significantly to medical sciences through innovative research and clinical advancements.

Professional Experience

Prof. Mustafa Arslan has built an impressive professional career, marked by significant roles in academia, research, and medical administration. Since 2021, he has been serving as a Professor in the Department of Surgical Medical Sciences at Gazi University, where he leads innovative research in experimental medicine and surgery. His administrative contributions include his role as the Director of the Experimental and Clinical Research Center at Gazi University since 2022, where he oversees advanced medical studies and laboratory experiments. He also chairs the Experimental Animals Ethics Committee, ensuring ethical compliance in medical research. Additionally, Prof. Arslan has been an Assistant Manager at the Research and Application Center at Gazi University since 2020, playing a key role in promoting interdisciplinary research collaborations. His long-standing membership on various ethics and academic committees at Gazi University further underscores his influence in shaping research policies and medical education. Over the years, he has supervised numerous doctoral dissertations, conducted specialized courses in anesthesia and systemic diseases, and participated in faculty governance. His vast experience in experimental and clinical medicine, combined with his leadership in medical education, makes him a distinguished figure in academic and medical circles.

Research Interest

Prof. Mustafa Arslan’s research interests span across various domains of medical and surgical sciences, with a particular focus on experimental medicine, anesthesiology, and ischemia-reperfusion injury models. His work in anesthesia research has explored the effects of different anesthetic agents on organ function, particularly in the context of liver and cardiovascular health. He has also conducted in-depth studies on systemic diseases and their impact on surgical outcomes. His research in ischemia-reperfusion injury has led to new insights into the mechanisms of cellular damage and potential therapeutic interventions. Prof. Arslan is also deeply interested in the ethical and methodological aspects of experimental research, leading various committees to ensure high standards in medical investigations. His expertise extends to the use of experimental animal models in medical research, where he has contributed to advancing surgical techniques and improving post-operative care. He remains committed to interdisciplinary research, collaborating with experts in pharmacology, physiology, and biomedical engineering to develop innovative medical solutions. Through his research, he aims to improve surgical outcomes, enhance patient safety, and contribute to the development of novel medical treatments and technologies.

Research Skills

Prof. Mustafa Arslan possesses a diverse set of research skills that make him a leader in medical and surgical sciences. His expertise in experimental research methodologies allows him to design and execute complex studies involving animal models and clinical trials. He is proficient in advanced surgical techniques, particularly in the study of ischemia-reperfusion injuries and anesthesia-related complications. His skills in electrophysiological assessments and biomedical instrumentation enable him to conduct high-precision studies on systemic diseases and their effects on the human body. Prof. Arslan is also well-versed in statistical analysis and research data interpretation, ensuring the accuracy and reliability of his findings. His experience in research ethics and laboratory management has equipped him with the ability to oversee large-scale experimental projects while maintaining compliance with ethical guidelines. Additionally, he has strong mentorship and academic writing skills, having supervised multiple doctoral theses and published extensively in peer-reviewed journals. His ability to integrate medical research with technological advancements makes him a valuable contributor to modern medical science.

Awards and Honors

Throughout his career, Prof. Mustafa Arslan has received numerous accolades in recognition of his contributions to medical research and education. His outstanding research achievements have earned him multiple institutional awards at Gazi University, where he has been recognized for his excellence in experimental and clinical medicine. His role in ethical research and academic governance has also been acknowledged through his appointments to key committee positions, demonstrating the trust placed in him by his peers. Additionally, his active participation in academic conferences, jury memberships, and doctoral supervision has been instrumental in shaping medical education and research in Turkey. Prof. Arslan’s contributions to anesthesia and ischemia-reperfusion injury research have gained significant recognition, positioning him as an influential figure in his field. His commitment to ethical research practices and continuous academic development further underscores his reputation as a dedicated researcher and educator. While his achievements are already substantial, his ongoing research and contributions to medical sciences suggest that more prestigious honors await him in the future.

Conclusion

Prof. Mustafa Arslan is a highly accomplished researcher, educator, and medical professional whose contributions to surgical and experimental medicine have had a profound impact. His expertise in anesthesia, ischemia-reperfusion injury models, and systemic disease research, combined with his leadership in medical ethics and experimental research, positions him as a leading figure in medical sciences. His extensive academic and administrative experience at Gazi University, along with his mentorship of future medical researchers, highlights his dedication to advancing medical knowledge and improving patient outcomes. His strong research skills, ethical leadership, and commitment to interdisciplinary collaboration make him a deserving candidate for prestigious research awards. While he has already earned significant recognition, expanding his international collaborations and securing more research grants could further enhance his global impact. Overall, Prof. Arslan’s remarkable career and contributions to medical research solidify his reputation as an outstanding scientist and educator in the field of medicine.

Publication Top Notes

  • Effects of Pomegranate Seed Oil on Lower Extremity Ischemia-Reperfusion Damage: Insights into Oxidative Stress, Inflammation, and Cell Death
    📌 Medicina, 2025-01-24 | DOI: 10.3390/medicina61020212
    Contributors: Ümmü Gülşen Bozok, Aydan İremnur Ergörün, Ayşegül Küçük, Zeynep Yığman, Ali Doğan Dursun, Mustafa Arslan
  • Effects of Cerium Oxide on Kidney and Liver Tissue Damage in an Experimental Myocardial Ischemia-Reperfusion Model of Distant Organ Damage
    📌 Medicina, 2024-12-11 | DOI: 10.3390/medicina60122044
    Contributors: Işın Güneş, Ali Doğan Dursun, Çağrı Özdemir, Ayşegül Küçük, Şaban Cem Sezen, Mustafa Arslan, Abdullah Özer
  • The Effect of Silymarin on Ischemia-Reperfusion Injury in Skeletal Muscles of Rats
    📌 Turkish Journal of Vascular Surgery, 2024-11-15 | DOI: 10.9739/tjvs.2024.09.038
    Contributors: Abdullah Ozer, Basak Kocak, Mustafa Arslan, Baris Mardin, Aysegul Kucuk, Saban Cem Sezen, Mustafa Hakan Zor, Mustafa Kavutcu
  • Ozone Administration Reduces Myocardial Ischemia Reperfusion Injury in Streptozotocin Induced Diabetes Mellitus Rat Model
    📌 Drug Design, Development and Therapy, 2024-09 | DOI: 10.2147/DDDT.S482309
    Contributors: Mehmet Gülcan, Hüseyin Demirtaş, Abdullah Özer, Zeynep Yığman, Ali Dursun, Mustafa Arslan, Gürsel Oktar
  • Evaluation of the Efficacy of Ozone Therapy on Liver Tissue in the Treatment of Sepsis in Rats with Cecal Perforation
    📌 Medicina, 2024-09-22 | DOI: 10.3390/medicina60091552
    Contributors: Selin Erel, Ayşegül Küçükk, Kürşat Dikmen, Esin Tekin, Zeynep Yığman, Müşerref Şeyma Ceyhan, Seda Gökgöz, Hasan Bostancı, Mustafa Arslan, Mustafa Kavutcu

Assist. Prof. Dr. Mohamed skiba | Pharmaceutics Award | Best Innovation Award

Assist. Prof. Dr. Mohamed skiba | Pharmaceutics Award | Best Innovation Award

Assist. Prof. Dr. Mohamed skiba, University of rouen, France

Dr. Mohamed Skiba, is a French national and a distinguished pharmaceutical scientist. He is a lecturer at the Faculty of Medicine and Pharmacy in Rouen, where he leads the Pharmaceutical Team within the Galenic Group. Dr. Skiba earned his Ph.D. in Pharmaceutical Sciences from the University of Paris XI in 1994 and has been active in pharmaceutical research since 1990, focusing on cyclodextrin and drug vectorization. With over 140 international publications, 80 patents, and numerous contributions to books and congresses, he is a recognized expert in pharmaceutical technology. Dr. Skiba is also an active member of several scientific societies, including the French Society of Chemistry and the French Association of Teachers of Technological Pharmacy. He is fluent in French, English, and Arabic.

Professional Profile:

Orcid

Suitability for Best Innovation Award: Dr. Mohamed SKIBA

Dr. Mohamed Skiba’s extensive work in pharmaceutical sciences, particularly his research in drug formulation and cyclodextrin technologies, positions him as a strong candidate for the Best Innovation Award. His innovations, reflected in his numerous patents and publications, highlight his ability to drive pharmaceutical advancements with real-world applications. His leadership in academic and research institutions further amplifies his impact, making him a deserving recipient of this prestigious award.

🎓Education:

Dr. Mohamed Skiba holds a Ph.D. in Pharmaceutical Sciences, which he earned in 1994 from the University of Paris XI, Southern Paris. His academic journey also includes a Diploma of Thorough Studies in Pharmacotechnology and Biopharmacy (1990) from the University of Paris XI in Châtenay-Malabry. In 1990, he obtained a Diploma in Veterinary Pharmaceuticals from the Faculty of Pharmacy, University of Clermont-Ferrand I. Additionally, Dr. Skiba completed advanced studies in pharmacology and electrophysiology with a Control of Research degree from the University of Poitiers in 1989. He also pursued studies in patent rights at the Faculty of Orsay, University of Paris-South, enriching his expertise in pharmaceutical and intellectual property matters.

🏢Work Experience:

Dr. Mohamed Skiba has been a lecturer at the Faculty of Medicine and Pharmacy, University of Rouen, France, since 1998. In this role, he teaches courses in galenic and industrial galenic pharmacy to both undergraduate and graduate students, while also leading the Pharmaceutical Team within the Galenic Group. His professional experience includes serving as a trainee at the Central Pharmacy of the Hospitals of Paris (PCH) and working as an Associated Attaché in Toxicology and Clinical Pharmacology at the Hospital of Corbeil-Essonnes, further enhancing his expertise in pharmaceutical technology and clinical applications.

🏅Awards & Recognition:

Dr. Mohamed Skiba is a prolific contributor to the field of pharmaceutical technology, holding over 80 patents that highlight his innovative work. He has authored 140 international publications and contributed to 9 book chapters, making significant scholarly impacts. Additionally, Dr. Skiba has presented 71 communications at prestigious scientific congresses, sharing his research and advancements with the global scientific community.

🔬Research Focus:

Dr. Skiba’s research primarily centers on pharmaceutical technology, with a particular focus on cyclodextrin and drug vectorization. His work involves improving drug delivery systems, studying bio-polymeric materials, and developing innovative pharmaceutical formulations. He has been involved in numerous pharmaceutical research projects since 1990, contributing to the advancement of drug delivery and formulation technologies.

Publication Top Notes:

  • Powder Self-Emulsifying Drug Delivery System for Mitotane: In Vitro and In Vivo Evaluation
  • In vitro dissolution of encapsulated or dispersed vitamin E and cholesterol is correlated with preservation of refrigerated ovine sperm
  • Exploring the Therapeutic Potential of Algerian Propolis: GC/MS Profiling, Protective Inclusion Complex, and In Silico Evaluation Against SARS‐CoV‐2 Main Proteases
  • Development of a Novel Cyclodextrin–Chitosan Polymer for an Efficient Removal of Pharmaceutical Contaminants in Aqueous Solution

 

 

Dr. Angela Fabiano | Pharmaceutics Awards | Best Researcher Award

Dr. Angela Fabiano | Pharmaceutics Awards | Best Researcher Award

Dr. Angela Fabiano,University of Pisa,Italy

Angela Fabiano is a senior researcher at the University of Pisa, Department of Pharmacy, specializing in drug delivery systems. She earned her Ph.D. in Science of Drugs and Bioactive Substances in 2016, with a focus on innovative pharmaceutical systems based on chitosan and its derivatives. Her research involves the synthesis, purification, and characterization of chitosan derivatives to enhance solubility and pharmaceutical applications, including nanosystems and hydrogels for drug delivery via ocular and oral routes. In 2020, she achieved the scientific qualification for associate professor and has authored over 30 publications, with around 800 citations.

Professional Profile:

Orcid

Scopus

Suitability for Best Researcher Award:

Angela Fabiano’s innovative research in drug delivery systems, significant academic contributions, and recognized scientific qualifications make her an outstanding candidate for the Best Researcher Award. Her work directly impacts the development of novel pharmaceutical systems, positioning her as a leader in her field.

🎓Education:

Angela Fabiano earned her Ph.D. in Science of Drugs and Bioactive Substances from the University of Pisa in 2016. Her doctoral thesis, titled “Innovative Pharmaceutical Systems Based on Chitosan and Its Derivatives,” focused on developing novel pharmaceutical systems using chitosan and its derivatives. Her research explored the synthesis, purification, and characterization of these derivatives to improve solubility and expand their pharmaceutical applications, particularly in the creation of advanced drug delivery systems. This work laid the foundation for her continued contributions to drug delivery research.

🏢Work Experience:

Angela Fabiano is currently a Senior Researcher at the Department of Pharmacy, University of Pisa. Her research focuses on drug delivery systems, specifically the synthesis, purification, and characterization of chitosan derivatives. She is dedicated to advancing the development of nanosystems and hydrogels for drug delivery through various routes, including ocular and oral. Her work aims to enhance the effectiveness and versatility of pharmaceutical applications, contributing significantly to the field of drug delivery.

🏅Awards & Achievements:

Angela Fabiano is currently a Senior Researcher at the Department of Pharmacy, University of Pisa. Her research focuses on drug delivery systems, including the synthesis, purification, and characterization of chitosan derivatives. She is also involved in the development of advanced nanosystems and hydrogels for drug delivery through ocular and oral routes. In 2020, she achieved scientific qualification for the role of Associate Professor at the University of Pisa. She has authored over 30 publications in journals with medium to high impact factors, and her work has been cited approximately 800 times, underscoring her significant contributions to the field.

Publication Top Notes:

  • Title: Cross-Linked Thiolated Hydroxypropyl-β-Cyclodextrin for Pulmonary Drug Delivery
  • Title: Olive Leaf Extracts from Three Italian Olive Cultivars Exposed to Drought Stress Differentially Protect Cells against Oxidative Stress
  • Title: Betaine- and L-Carnitine-Based Ionic Liquids as Solubilising and Stabilising Agents for the Formulation of Antimicrobial Eye Drops Containing Diacerein
  • Title: Bergamot Essential Oil: A Method for Introducing It in Solid Dosage Forms
  • Title: Thiolated Hydroxypropyl-β-Cyclodextrin: A Potential Multifunctional Excipient for Ocular Drug Delivery

 

 

 

 

Assist. Prof. Dr. Vipin Kumar | Drug delivery Awards | Best Researcher Award

Assist. Prof. Dr. Vipin Kumar | Drug delivery Awards | Best Researcher Award

Assist. Prof. Dr. Vipin Kumar , Department of Pharmaceutical Sciences, Gurukul Kangri (Deemed to be University) Haridwar , India

Dr. Vipin Kumar is an accomplished Assistant Professor in the Department of Pharmaceutical Sciences at Gurukul Kangri (Deemed to be University), Haridwar, India. With 17 years of teaching and research experience, he specializes in novel drug delivery systems, bioavailability enhancement, and drug pharmacokinetics. He co-directs the Pharmaceutics Division, chairs the Board of Studies and Institutional Animal Ethics Committee, and actively contributes to various committees within the university. An alumnus of Dibrugarh University with a Ph.D. and M.Pharm in Pharmaceutics, and H.N.B. Garhwal University with a B.Pharm, Dr. Kumar has also consulted for prestigious institutions like ECLAC and the Inter-American Development Bank. He has visited Stony Brook University, USA, and is a reviewer for esteemed journals. His research focuses on biopolymers, biomedical polymer composites, and the development of herbo-mineral nano dosage forms.

Professional Profile:

Google Scholar

🎓Education:

Dr. Vipin Kumar holds a Ph.D. in Pharmaceutics from Dibrugarh University, Assam, India, awarded in 2015. He completed his M.Pharm in Pharmaceutics from the same institution in 2006 and obtained his B.Pharm from H.N.B. Garhwal University, Srinagar, Uttarakhand, India, in 2004. His academic prowess is further highlighted by his impressive performances in national-level exams, including qualifying the Graduate Aptitude Test in Engineering (GATE) in 2003 and 2004 with notable percentiles, as well as passing the National Institute of Pharmaceutical Education and Research (NIPER) Entrance Examination in June 2004.

🏢Work Experience:

Dr. Vipin Kumar is currently serving as Assistant Professor and Incharge-Pharmaceutics Division at the Department of Pharmaceutical Sciences, Faculty of Pharmaceutical Sciences, Gurukul Kangri (Deemed to be University), Haridwar, India. He previously held the position of Head of Department at Gurukul Kangri University, Haridwar. Dr. Kumar actively contributes to various committees including the Placement Cell, Corporate Affairs and Outreach Cell, IQAC, Institutional Animal Ethics Committee, External Affairs Interface Cell, and Research Degree Committee within the university. He is recognized as a reviewer for esteemed journals such as Polymer Bulletin, Starch, Drug Delivery, and others. His consultancy roles include contributions to the Economic Commission for Latin America and the Caribbean (ECLAC) and the Inter-American Development Bank (BID). Dr. Kumar’s professional journey includes valuable project experience, including his work on mucoadhesive microspheres and gamma scintigraphic mucoadhesivity assessment at the Institute of Nuclear Medicine and Allied Sciences, New Delhi. He also gained hospital training experience at H.N.B. Govt. Base Hospital, Srinagar (Garhwal), Uttaranchal, India, in February 2004.

🏆Awards and Achievements:

Dr. Vipin Kumar holds the position of Treasurer at the Gurukul Kangri University Teachers Association (GUTA) and serves as a member of Expert Committees for course approval and affiliation constituted by Uttarakhand Technical University, Dehradun. He has enriched his academic experience as a Visiting Scholar at Stony Brook University, New York, USA. Dr. Kumar has made significant contributions to the development of herbo-mineral nano dosage forms and sustained release drug delivery systems, leveraging his expertise in novel drug delivery systems, bioavailability enhancement, drug pharmacokinetics, and biomedical polymers. His research endeavors also include pioneering work on mucoadhesive microspheres and gamma scintigraphic mucoadhesivity assessment, conducted at prestigious institutions like the Institute of Nuclear Medicine and Allied Sciences, New Delhi

Publication Top Notes:

 

Prof. Franciska Erdo | Drug delivery Award | Best Researcher Award

Prof. Franciska Erdo | Drug delivery Award | Best Researcher Award

Prof. Franciska Erdo , Pázmány Péter Catholic University , Hungary

Franciska Vidáné Dr. Erdő, born on May 28, 1964, in Budapest, is a distinguished full professor and lab head at Pázmány Péter Catholic University, Faculty of Information Technology and Bionics. She holds a PhD in pharmacology from Semmelweis University and has extensive experience in both academic and research institutions, including the University of Tours, Charité Medizinische Universität in Berlin, and the Max-Planck Institute in Cologne. Her research focuses on drug research and development, evidenced by her numerous fellowships and scholarships. She has supervised over 31 graduate students and postdoctoral fellows and has been recognized for her teaching excellence. Dr. Erdő has also contributed significantly to scientific literature and education, particularly in the fields of molecular bionics and biomedical innovation.

Professional Profile:

Orcid

Education:

Franciska Vidáné Dr. Erdő earned her MSc in Pharmacy from Semmelweis University in 1987, graduating with top grades. She continued her education at the same institution, achieving a University Doctor degree in Pharmacology with summa cum laude honors in 1994. In 1997, she completed her PhD in Pharmacology, also with summa cum laude distinction, at Semmelweis University, Faculty of Pharmacy. Most recently, in 2019, she received her habilitation from Pázmány Péter Catholic University, Faculty of Information Technology and Bionics.

Work Experience:

Franciska Vidáné Dr. Erdő has held numerous esteemed positions throughout her career. Since 2024, she has been serving as a Full Professor and Lab Head at Pázmány Péter Catholic University, Faculty of Information Technology and Bionics. Prior to this, from 2019 to 2024, she was an Associate Professor and Lab Head at the same institution. She was also a Guest Researcher at the University of Tours, France, in 2022. From 2014 to 2019, she worked as a Senior Research Fellow and Lab Head at Pázmány Péter Catholic University. Her earlier roles include serving as a Senior Research Fellow and Lab Head at SOLVO Biotechnology from 2007 to 2014, and holding a scientific scholarship at Charité Medizinische Universität in Berlin, Germany, from 2005 to 2006. She also worked as a Senior Research Fellow at IVAX Drug Research Institute from 2003 to 2007 and held a Max Planck Fellowship at the Max-Planck Institute für neurologische Forschung in Cologne, Germany, from 2000 to 2003. Her earlier positions include Senior Research Fellow roles at Sanofi-Synthelabo Chinoin from 1997 to 2000 and Biorex R&D Co. from 1995 to 1997. She began her career as a Research Fellow at the Institute for Drug Research from 1990 to 1995 and as a Junior Research Fellow at the same institute from 1987 to 1990.

Publication Top Notes:

1.Fluid Dynamics Optimization of Microfluidic Diffusion Systems for Assessment of Transdermal Drug Delivery: An Experimental and Simulation Study

  • Journal: Scientia Pharmaceutica
  • Publication Date: June 2024

2. Progress in Topical and Transdermal Drug Delivery Research—Focus on Nanoformulations

  • Journal: Pharmaceutics
  • Publication Date: June 2024

3. Transdermal Delivery of α-Aminophosphonates as Semisolid Formulations—An In Vitro-Ex Vivo Study

  • Journal: Pharmaceutics
  • Publication Date: May 2023